Alternatives to Sanofi
Sanofi is a Biotech tool: a global biopharmaceutical company focused on human health, developing and manufacturing innovative medicines and vaccines, driven by R&D and AI. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Sanofi
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
BiotechMedTechUpdated 1 Jul 2026
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
BiotechDrug DiscoveryUpdated 12 Oct 2026
Lexeo Therapeutics3.0 out of 5 (1)Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
BiotechMedTechUpdated 1 May 2026
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
BiotechMedTechUpdated 25 Jun 2026
Amicus TherapeuticsNot ratedBiotechnology company focused on developing treatments for rare metabolic diseases.
BiotechMedTechUpdated 13 Sept 2026
Harmony Biosciences HoldingsNot ratedBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
BiotechMedTechUpdated 30 Aug 2026
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
BiotechMedTechUpdated 28 Sept 2026- PRProNAi TherapeuticsNot rated
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
BiotechDrug DiscoveryUpdated 23 Aug 2026
AlectorNot ratedBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
BiotechMedTechUpdated 1 May 2026
ProteinQureNot ratedBiotech company using AI and computational platforms to design novel peptide therapeutics.
BiotechDrug DiscoveryUpdated 7 Sept 2026
Integra TherapeuticsNot ratedBiotech company developing next-generation gene writing tools for advanced therapies.
BiotechGene TherapyUpdated 28 May 2026
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
BiotechDrug DiscoveryUpdated 13 Sept 2026
TharimmuneNot ratedBiotechnology company developing novel immunotherapies for cancer.
BiotechMedTechUpdated 12 Oct 2026
RezoluteNot ratedBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
BiotechMedTechUpdated 25 Sept 2026
Leap TherapeuticsNot ratedLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
BiotechHealthTechUpdated 25 May 2026
C4 TherapeuticsNot ratedBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
BiotechDrug DiscoveryUpdated 13 Sept 2026
ANI PharmaceuticalsNot ratedDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
BiotechPharmaceuticalsUpdated 26 Sept 2026
MacroGenicsNot ratedBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
BiotechMedTechUpdated 30 Aug 2026
Adicet Bio3.0 out of 5 (1)Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
BiotechHealthTechUpdated 17 Oct 2026
Showing the 20 closest matches. See the rest on the Sanofi profile.